课题基金 / 基金详情

Effects of increased noradrenergic activity by yohimbine administration on learning and attention in patients with major depression disorder

Effects of increased noradrenergic activity by yohimbine administration on learning and attention in patients with major depression disorder
育亨宾给药增加去甲肾上腺素能活性对重度抑郁症患者学习和注意力的影响
批准号:
240462297
负责人:
Professorin Dr. Linn Kristina Kühl
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2017-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
压力在重度抑郁症(MDD)的发展和维持中起着重要作用。事实上,各种研究表明MDD患者的生理应激调节系统,即下丘脑-垂体-肾上腺(HPA)轴和蓝斑-去甲肾上腺素能(LC-NA)系统发生了不适应的变化。在中心水平上,LC-NA系统的变化已经被证明。一些研究可以显示重度抑郁症患者肾上腺素受体反应性的变化(α 2-肾上腺素能受体的上调)。这似乎在早期生活创伤的重度抑郁症患者中尤其如此。与HPA轴相比,LC-NA系统不仅影响生理应激反应,而且对认知功能也有核心影响。事实上,在健康个体中,NA对注意力、学习和记忆等认知功能的影响已经得到证实。综上所述,NA似乎对记忆巩固有增强作用。尽管注意力和记忆等认知领域的缺陷是重度抑郁症的核心症状,但到目前为止,去甲肾上腺素能系统与记忆过程的关系还很少被研究。因此,我们的研究小组首次研究了通过给予α 2受体阻滞剂育亨宾来刺激去甲肾上腺素能对不同记忆功能的影响。在那里,我们发现与健康对照组相比,重度抑郁症患者记忆巩固的改善更为明显。此外,我们发现育亨宾与早期生活创伤的巩固改善有关。在这个项目中,我们的目标是首次调查,如果通过给予α 2受体阻滞剂育喜宾的去甲肾上腺素能刺激,与健康对照相比,在a)学习和b)注意力过程中,MDD患者是否也有更明显的影响。因此,我们将研究a)注意过程,使用点探针任务的情感变体,特别关注抑郁的消极偏见;b)习得和消退过程,使用恐惧条件反射范式。此外,我们将调查早期生活创伤对这些关系的影响。因此,我们计划调查有无早期生活创伤的重度抑郁症患者。基于这些原因,我们计划采用双盲、安慰剂对照、重复测量设计,对40名重度抑郁症患者(20名有/ 20名没有早期生活创伤)和40名健康对照者(20名有/ 20名没有早期生活创伤,年龄、性别和教育程度相匹配)进行调查。本研究的结果将提高我们对认知缺陷和α 2-肾上腺素能系统在重度抑郁症患者中的作用的理解,从而支持通过考虑这些关系来开发新的治疗策略。
英文摘要
Stress plays a major role in the development and maintenance of major depression disorder (MDD). Indeed, various studies demonstrated maladaptive changes in physiological stress regulation systems of MDD patients, i.e. in the hypothalamus-pituitary-adrenal (HPA) axis and the locus coeruleus-noradrenergic (LC-NA) system. On a central level, changes of the LC-NA system have been demonstrated. Several studies could show changes of the adrenoreceptor responsiveness (up-regulation of alpha2-adrenergic receptors) in MDD patients. This seems to be the case especially in MDD patients with early life traumata. Comparable to the HPA axis, the LC-NA system influences not only the physiological stress response, but has also central influence with effects on cognitive functions. Indeed, NA effects on cognitive functions such as attention, learning and memory have been demonstrated in healthy individuals. In summary, NA seems to have enhancing effects on memory consolidation. Even though deficits in cognitive domains such as attention and memory are core symptoms of MDD, the relationship of the noradrenergic system and memory processes has rarely been investigated so far. Therefore, our research group investigated in a first study the influence of noradrenergic stimulation via administration of the alpha2-receptor blocker yohimbine on different memory functions. There,, we found an improvement of memory consolidation that was even more pronounced in MDD patients compared to healthy controls. Additionally, we found associations of yohimbine triggered consolidation improvements to early life traumata.In this project, we aim to investigate for the first time, if noradrenergic stimulation via administration of the alpha2-receptor blocker yohimbine has also more pronounced effects in MDD patients compared to healthy controls for a) learning and b) attention processes. Therefore, we will examine a) attention processes using an emotional variant of the Dot-Probe-task with a special focus on the depressive negativity bias and b) acquisition and extinction processes using a fear conditioning paradigm. Additionally, we will investigate the influence of early life traumata on these relationships. Thus, we plan to investigate MDD patients with and without early life traumata.For these reasons, we plan to investigate 40 MDD patients (20 with/ 20 without early life traumata) and 40 healthy controls (20 with/ 20 without early life traumata; matched for age, sex and educational status) in a double-blind, placebo controlled, repeated measures design.Results of this study will improve our understanding of cognitive deficits and the role of alpha2-adrenergic system in MDD patients, and thus support the development of new therapeutic strategies by considering these relations.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00213-021-05969-7
发表时间: 2021-12
期刊: Psychopharmacology
影响因子: 3.4
作者: [Kuehl LK, Deuter CE, Nowacki J, Ueberrueck L, Wingenfeld K, Otte C]
通讯作者: Otte C
Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences
育亨宾增强去甲肾上腺素能活性和有或没有不良童年经历的重度抑郁症患者的差异性恐惧调节
DOI: 10.1016/j.pnpbp.2019.109751
发表时间: 2020
期刊: Progress in Neuro-Psychopharmacology and Biological Psychiatry
影响因子: 5.6
作者: [Linn K. Kuehl, Christian E. Deuter, Julian Hellmann-Regen, Michael Kaczmarczyk, Christian Otte, Katja Wingenfeld]
通讯作者: Katja Wingenfeld
Telomere length in individuals with and without major depression and adverse childhood experiences
有或没有重度抑郁症和不良童年经历的个体的端粒长度
DOI: 10.1016/j.psyneuen.2022.105762
发表时间: 2022
期刊: Psychoneuroendocrinology
影响因子: 3.7
作者: [de Punder, Deuter, Martens, . . . Entringer]
通讯作者: . . . Entringer
DOI: 10.3389/fpsyt.2018.00610
发表时间: 2018-11-27
期刊: FRONTIERS IN PSYCHIATRY
影响因子: 4.7
作者: [de Punder, Karin, Entringer, Sonja, Kuehl, Linn K.]
通讯作者: Kuehl, Linn K.
海外基金